A protein array on a lysate of tumors treated with MTX alone displayed a more than 1.5 fold increase of CCL17, CXCL11, CD160 and CXCL10, as compared to control tumor lysate (Fig. 6G). This evidence concerns the gene CD160 and neoplasm.